These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 392396)

  • 1. [Successful treatment of Wiscott-Aldrich syndrome with transfer factor].
    Endre L; Nékám K; Osváth P; Nagy M; Károly U; Uhl K
    Orv Hetil; 1979 Sep; 120(39):2361-6. PubMed ID: 392396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Discrepancy between the clinical and immunologic picture of in vitro diagnosis during transfer factor therapy in a patient with Wiscott-Aldrich syndrome].
    Schütt C; Eggers G; Schröder I; Kruse H; Schulz M; Blau HJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):677-84. PubMed ID: 6198251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of transfer factor treatment of human warts.
    Stevens DA; Ferrington RA; Merigan TC; Marinkovich VA
    Clin Exp Immunol; 1975 Sep; 21(3):520-4. PubMed ID: 1106927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary experience with the treatment of a case of Wiskott-Aldrich syndrome with transfer factor].
    Balsamo V; Brai M; Mogavero S; Tolone G; La Grutta A
    Minerva Pediatr; 1977 Mar; 29(10):651-5. PubMed ID: 875932
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephropathy in the Wiskott-Aldrich syndrome.
    Spitler LE; Wray BB; Mogerman S; Miller JJ; O'Reilly RJ; Lagios M
    Pediatrics; 1980 Sep; 66(3):391-8. PubMed ID: 7422429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F; Segni G; Stabile A; Ammirati P; Aiuti F
    Minerva Pediatr; 1978 Apr; 30(8):609-13. PubMed ID: 661768
    [No Abstract]   [Full Text] [Related]  

  • 8. The oldest survivor with Wiskott-Aldrich syndrome.
    Pritikin RI; Fudenberg HH
    Metab Pediatr Ophthalmol; 1980; 4(3):169-71. PubMed ID: 7453283
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal immune responses in the ocular presentation of Wiskott-Aldrich syndrome.
    Guss RB; McCulley JP
    Ann Ophthalmol; 1982 Nov; 14(11):1058-60. PubMed ID: 7181336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wiskott-Aldrich syndrome with partial response to transfer factor.
    Mackie RM; Alcorn MJ; Stevenson RD; Cochran T; McSween RN
    Br J Dermatol; 1978 May; 98(5):567-71. PubMed ID: 656329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Letter: Attempt of treatment of the Wiskott-Aldrich syndrome].
    Juretić M
    Lijec Vjesn; 1972 Oct; 94(10):528-9. PubMed ID: 4680676
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transfer factor (its use in immunotherapy of neoplasms and other diseases)].
    Zduńczyk A
    Wiad Lek; 1980 Jun; 33(11):877-81. PubMed ID: 6999743
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the antibody dependent cytotoxicity under the effect of transfer factor therapy. Preliminary report].
    Láng I; Nékám K; Török K; Gergely P
    Orv Hetil; 1979 Jun; 120(25):1491-5. PubMed ID: 471469
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic prospects in some immune deficiency syndromes and other pathological conditions connected with immune disorders].
    Kraj M; Cieśluk S
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):327-35. PubMed ID: 793282
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfer factor therapy: evidence for nonspecificity.
    Ballow M; Dupont B; Hansen JA; Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):457-61. PubMed ID: 125119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Transfer factor". Experimental findings and prospects for its clinical use].
    Medunitsyn NV
    Patol Fiziol Eksp Ter; 1977; (1):75-80. PubMed ID: 325478
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfer factor therapy in the Wiskott-Aldrich syndrome. Results of long-term follow-up in 32 patients.
    Spitler LE
    Am J Med; 1979 Jul; 67(1):59-66. PubMed ID: 463917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.